Henri Godbold, MD
Geriatric Medicine · Detroit, MINPI 1407012834
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations.
Across 31 payments — averaging $33.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$197
- Lilly USA, LLC$151
- GSK$139
- E.r. Squibb & Sons, L.L.C.$116
- Tris Pharma Inc$110
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$105
- plus $213 from 7 others
What the payments were for
- Food & beverage$1,031100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 10 | $197 |
| Lilly USA, LLC | 5 | $151 |
| GSK | 2 | $139 |
| E.r. Squibb & Sons, L.L.C. | 1 | $116 |
| Tris Pharma Inc | 1 | $110 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $105 |
| Vivus LLC | 4 | $67 |
| Dexcom, Inc. | 1 | $47 |
| Sunovion Pharmaceuticals Inc. | 2 | $29 |
| Redhill Biopharma Inc. | 1 | $24 |
| Pfizer | 1 | $18 |
| Phadia US Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SHINGRIX$124
- ZEPOSIA$116
- Quillichew ER$110
- Dyanavel XR$110
- Quillivant$110
- CYCLOSET$105
How this compares
$1,031 in reported general payments places this provider in the 85th percentile of 168 geriatric medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 77 | $1,325 |
| Levetiracetam | 14 | $672 |
| Lisinopril | 12 | $200 |
| Famotidine | 11 | $65 |
| Carvedilol | 11 | $50 |
| Amlodipine Besylate | 15 | $45 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Detroit
- Saket SaxenaDetroit$11K
- Hasan ArratDetroit$1K
- Mohammad KangDetroit$443
- Hina HussainiDetroit$269
- Gerald DaneshvarHamtramck$23K
- Jailan ElayoubiDearborn$20K
- Grace JenqAnn Arbor$12K
- Afriyie GrayGrand Rapids$12K
- Bnan RazokyTroy$11K
- Randolph SchumacherFlint$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.